Moderate alcohol consumption associated with decreased risk of heart failure
the ONA take:
According to a new study published online in the European Heart Journal, researchers have found that drinking up to seven alcoholic drinks per week in early to middle age is associated with 20% decreased risk for developing heart failure in men.
For the study, researchers from Brigham and Women's Hospital in Boston, Massachusetts, analyzed data from 14,629 people aged 45-64 years from the Atherosclerosis Risk in Communities Study conducted between 1987 and 1989. Participants were followed for 24-25 years until the end of 2011.
Researchers asked them about their alcohol consumption at the beginning of the study and at the three subsequent visits every 3 years years. During the follow-up period, 1,271 men and 1,237 women developed heart failure.
Results showed that those who drank up to seven drinks per week had the lowest rate of heart failure and those were considered former drinkers had the highest.
After adjusting for other factors, researchers found that men who drank up to seven drinks per week had a 20% decreased risk for developing heart failure compared with those who did not drink, and women who drank the same amount had a 16% reduced risk of heart failure. The findings suggest that moderate consumption of alcohol may provide protective benefits against heart failure.
Drinking up to seven alcoholic drinks per week is associated with 20% decreased risk for developing heart failure in men.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|